TaiAn Technologies Corp.
Overview
TaiAn Technologies Corp. is a private equity firm and management company for biotechnology venture capital funds that invests in bio-tech and healthcare related technology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AnHorn Medicines | Apr 2023 | Series A | Co-investor |
| Aprinoia Therapeutics | Dec 2021 | Series C | Co-investor |
| Sapience Therapeutics | Jul 2016 | Series A | Co-investor |
| Rege Nephro Co., Ltd. | Jul 2026 | Debt | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is TaiAn Technologies Corp. based?
TaiAn Technologies Corp. is headquartered in Taipei, Taiwan.
When was TaiAn Technologies Corp. founded?
TaiAn Technologies Corp. was founded in 2002.
How many portfolio companies does TaiAn Technologies Corp. have?
TaiAn Technologies Corp. has 4 portfolio companies in Caplight's dataset.
What are some companies in TaiAn Technologies Corp.'s portfolio?
Portfolio companies visible on Caplight include AnHorn Medicines, Aprinoia Therapeutics, Sapience Therapeutics, Rege Nephro Co., Ltd..
What was TaiAn Technologies Corp.'s most recent investment shown here?
TaiAn Technologies Corp.'s most recent investment in this portfolio sample was in Rege Nephro Co., Ltd. in 2026.
What sectors does TaiAn Technologies Corp. focus on?
TaiAn Technologies Corp. focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does TaiAn Technologies Corp. focus on?
TaiAn Technologies Corp. typically invests at the Early stage.